The Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2), coded by <i>NFE2L2</i> gene, has emerged as a key player in chemoresistance and tumoral progression across multiple cancer types, including BC. Here, NFE2L2 is linked to breast cancer.